Zevra therapeutics to be added to russell 2000® and russell 3000® indexes effective june 26, 2023

Celebration, fla., june 20, 2023 (globe newswire) -- zevra therapeutics, inc. (nasdaqgs: zvra) (zevra, or the company, formerly kempharm, inc.), a rare disease therapeutics company, announced its expected addition to the broad-market russell 3000® index and small-cap russell 2000® index in accordance with the 2023 russell indexes annual reconstitution. zevra anticipates that its inclusion in the russell indexes will be effective after the u.s. market opens on monday, june 26, 2023.
ZVRA Ratings Summary
ZVRA Quant Ranking